These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6610654)
21. Early loss of precursors of CTL and IL 2-producing cells in the development of neonatal tolerance to alloantigens. Carnaud C; Ishizaka ST; Stutman O J Immunol; 1984 Jul; 133(1):45-51. PubMed ID: 6233373 [TBL] [Abstract][Full Text] [Related]
22. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells. Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193 [TBL] [Abstract][Full Text] [Related]
23. Induction of cytolytic T lymphocytes by mitogenic lectins is specifically inhibited by anti-Lyt-2 antibodies. Gullberg M; Larsson EL Eur J Immunol; 1983 Jun; 13(6):476-80. PubMed ID: 6602709 [TBL] [Abstract][Full Text] [Related]
24. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response. Yang SS; Malek TR; Hargrove ME; Ting CC J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614 [TBL] [Abstract][Full Text] [Related]
25. Production of lymphokines by murine cortisone-resistant thymocytes, stimulated by concanavalin A. I. Comparison of optimal culture conditions for proliferative response and interleukin-2 production. Pajtasz E; Kuśnierczyk P; Kisielow P Arch Immunol Ther Exp (Warsz); 1983; 31(4):437-42. PubMed ID: 6608337 [TBL] [Abstract][Full Text] [Related]
26. Semi-automated limit-dilution assay and clonal expansion of all T-cell precursors of cytotoxic lymphocytes. Wilson A; Chen WF; Scollay R; Shortman K J Immunol Methods; 1982 Aug; 52(3):283-306. PubMed ID: 6982296 [No Abstract] [Full Text] [Related]
27. Induction of suppressor T cells by interleukin 2. Ting CC; Yang SS; Hargrove ME J Immunol; 1984 Jul; 133(1):261-6. PubMed ID: 6233372 [TBL] [Abstract][Full Text] [Related]
28. Cyclosporin A inhibits IL 2-driven proliferation of human alloactivated T cells. Buurman WA; Ruers TJ; Daemen IA; van der Linden CJ; Groenewegen G J Immunol; 1986 Jun; 136(11):4035-9. PubMed ID: 2939138 [TBL] [Abstract][Full Text] [Related]
29. Enrichment of IL-2-producer T cells from mouse spleen by use of Bauhinia purpurea lectin. Imai Y; Osawa T Scand J Immunol; 1983 Sep; 18(3):217-24. PubMed ID: 6226088 [TBL] [Abstract][Full Text] [Related]
30. The enhancement of T cell proliferation by L-dopa is mediated peripherally and does not involve interleukin-2. Carr L; Tucker A; Fernandez-Botran R J Neuroimmunol; 2003 Sep; 142(1-2):166-9. PubMed ID: 14512176 [TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory effects of neurotropin through the recovery of interleukin-2 production in autoimmune-prone (NZB/NZW) F1 mice. Naiki M; Suehiro S; Imai Y; Osawa T Int J Immunopharmacol; 1989; 11(6):663-71. PubMed ID: 2807638 [TBL] [Abstract][Full Text] [Related]
32. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma. Maier T; Holda JH J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798 [TBL] [Abstract][Full Text] [Related]
33. Enhanced proliferation of murine T cell lines following interaction of poly(Glu60,Phe40) (GPhe) and antigen-presenting accessory cells. II. The role of accessory cells and cytokines in the activity of GPhe on antigen-independent proliferation. Grun JL; Liu DC; Maurer PH Cell Immunol; 1990 Aug; 129(1):213-27. PubMed ID: 1694731 [TBL] [Abstract][Full Text] [Related]
34. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. Altman A; Theofilopoulos AN; Weiner R; Katz DH; Dixon FJ J Exp Med; 1981 Sep; 154(3):791-808. PubMed ID: 6456321 [TBL] [Abstract][Full Text] [Related]
35. Production and response to interleukin 2 in vitro and in vivo after bone marrow transplantation in mice. Merluzzi VJ; Welte K; Last-Barney K; Mertelsmann R; Souza L; Boone T; Savage DM; Quinn D; O'Reilly RJ J Immunol; 1985 Apr; 134(4):2426-30. PubMed ID: 3919093 [TBL] [Abstract][Full Text] [Related]
36. Effect of concanavalin A treatment on the allogeneic response of mice to challenge with P 815 mastocytoma: interleukin 2 treatment reverses concanavalin A suppression in vivo. Ekstedt RD; Merdian DJ Cell Immunol; 1984 May; 85(2):447-58. PubMed ID: 6424952 [TBL] [Abstract][Full Text] [Related]
37. Interleukin 2 induces both, growth and maturation of lectin reactive Lyt-2+ but not Lyt-2-precursor cells and regulates the cytolytic potential of effector cells. Hochgeschwender U; Diamantstein T; Prester M; Nerz G; Simon MM Immunobiology; 1986 Apr; 171(3):274-301. PubMed ID: 3086217 [TBL] [Abstract][Full Text] [Related]
38. Isoprinosine restores in vitro T lymphocyte functions of cyclophosphamide immunosuppressed mice. Barasoain I; Rejas MT; Portoles MP; Ojeda G; Rojo JM Int J Immunopharmacol; 1987; 9(4):489-96. PubMed ID: 2442109 [TBL] [Abstract][Full Text] [Related]
39. Urtica dioica agglutinin, a new mitogen for murine T lymphocytes: unaltered interleukin-1 production but late interleukin 2-mediated proliferation. Le Moal MA; Truffa-Bachi P Cell Immunol; 1988 Aug; 115(1):24-35. PubMed ID: 3261205 [TBL] [Abstract][Full Text] [Related]
40. T cell-specific suppressor factor(s) with regulatory influence on interleukin 2 production and function. Kramer M; Koszinowski U J Immunol; 1982 Feb; 128(2):784-90. PubMed ID: 6459386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]